Pact With Systagenix Wound Management to Allow ECI Biotech to Open Worcester Factory, New Jobs Created  
9/23/2010 9:42:38 AM

Telegram -- WORCESTER — ECI Biotech, a privately held company that develops protein-based sensors to detect pathogens, has entered into licensing and manufacturing agreements with Systagenix for production of diagnostic sensors for wound management.